Glass House Brands (GLAS) Consolidated Net Income (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Consolidated Net Income of -$17.0 million for Q1 2026, down 9.72% quarter-over-quarter from -$15.5 million in Q4 2025.
Glass House Brands (GLAS) Consolidated Net Income (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Consolidated Net Income for 7 consecutive years, with -$17.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Consolidated Net Income changed N/A year-over-year to -$17.0 million; the TTM figure through Mar 2026 stood at -$35.9 million (down 458.1% YoY), while the FY2025 annual figure was -$29.0 million, down 4115.53% from the prior year.
- Consolidated Net Income eased to -$17.0 million in Q1 2026 per GLAS's latest filing, from -$15.5 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at $15.2 million in Q3 2022 and bottomed at -$19659.4 billion in Q2 2023.
- Historically, Consolidated Net Income has averaged -$2470.7 billion across 5 years, with a median of -$17.0 million in 2026.
- Annual changes were most pronounced in 2022 — Consolidated Net Income surged 100.0% — and 2023, when it slumped 58.76%.
- Glass House Brands' Consolidated Net Income stood at -$28.4 million in 2022, then plunged by 49.89% to -$42.6 million in 2023, then jumped by 123.57% to $10.0 million in 2024, then tumbled by 254.4% to -$15.5 million in 2025, then dropped by 9.72% to -$17.0 million in 2026.
- Business Quant data shows GLAS's Consolidated Net Income at -$17.0 million in Q1 2026, -$15.5 million in Q4 2025, and -$12.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Glass House Brands | 829.33 Mn | 810.78 Mn | 15.77 Mn | -6.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.01 Mn |
| Dec 31, 2025 | -15.50 Mn |
| Sep 30, 2025 | -12.19 Mn |
| Jun 30, 2025 | 8.74 Mn |
| Jun 30, 2024 | 10.04 Mn |
| Dec 31, 2023 | -42.60 Mn |
| Sep 30, 2023 | 6.28 Mn |
| Jun 30, 2023 | -19,659.40 Bn |
| Mar 31, 2023 | -32.41 Mn |
| Dec 31, 2022 | -28.42 Mn |
| Sep 30, 2022 | 15.17 Mn |
| Jun 30, 2022 | -12,459.44 Bn |
| Mar 31, 2022 | -20.41 Mn |
| Dec 31, 2021 | -22.46 Mn |
| Sep 30, 2021 | -6,955.68 Bn |
| Jun 30, 2021 | -13,606.55 Bn |
| Mar 31, 2021 | -13.15 Mn |
| Dec 31, 2020 | -6.16 Mn |
| Sep 30, 2020 | -1.15 Mn |
| Mar 31, 2020 | -5.14 Mn |